ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

KZR Kezar Life Sciences Inc

0.833
-0.0217 (-2.54%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Kezar Life Sciences Inc KZR NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0217 -2.54% 0.833 18:45:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.86 0.8336 0.86 0.8574 0.8547
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/4/202415:01BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
14/3/202415:01BWKezar Life Sciences Reports Fourth Quarter and Year End 2023..
08/3/202415:05BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
28/2/202415:01BWKezar Life Sciences to Participate in the TD Cowen 44th..
26/2/202417:30BWEverest Medicines and Kezar Life Sciences Receive IND..
14/2/202405:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
17/1/202416:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202415:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202407:36EDGAR2Form 8-K - Current report
04/12/202315:28EDGAR2Form 8-K - Current report
21/11/202315:01BWKezar Life Sciences to Present at the 6th Annual Evercore..
13/11/202315:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:01BWKezar Life Sciences Reports Third Quarter 2023 Financial..
09/11/202315:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:03BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
27/10/202315:06EDGAR2Form 8-K - Current report
09/10/202316:56BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
03/10/202315:14EDGAR2Form 8-K - Current report
03/10/202315:10BWKezar Life Sciences Announces Strategic Restructuring to..
20/9/202319:30DJNStocks to Watch: FedEx, Kezar Life Sciences, Transcat
20/9/202317:30BWKezar Life Sciences and Everest Medicines Enter into an..
31/8/202315:01BWKezar Life Sciences to Participate in Three Upcoming..
10/8/202315:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202315:06EDGAR2Form 8-K - Current report
10/8/202315:01BWKezar Life Sciences Reports Second Quarter 2023 Financial..
04/8/202315:03BWKezar Announces Inducement Grants Under NASDAQ Listing Rule..
26/7/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202315:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/7/202315:37EDGAR2Form 8-K - Current report
24/7/202315:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202315:01BWKezar Announces Inducement Grant Under NASDAQ Listing Rule..
09/6/202315:01BWKezar Announces Inducement Grants Under NASDAQ Listing Rule..
31/5/202306:00BWKezar Life Sciences to Participate in the Jefferies..
11/5/202315:01BWKezar Life Sciences Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock